<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:department>Electronic Engineering and Physics</gtr:department><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/ACD6437C-C203-4D72-B0AF-9A502AB5C3BF"><gtr:id>ACD6437C-C203-4D72-B0AF-9A502AB5C3BF</gtr:id><gtr:firstName>William</gtr:firstName><gtr:otherNames>Henry</gtr:otherNames><gtr:surname>McLean</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A51ABAD7-AD25-491A-BB9E-515BEF9F4166"><gtr:id>A51ABAD7-AD25-491A-BB9E-515BEF9F4166</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>Andrew</gtr:otherNames><gtr:surname>Campbell</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802645"><gtr:id>73179186-3FF2-409E-B473-01C243DE81CC</gtr:id><gtr:title>Exploiting Non-Linear Acoustics for Enhanced Molecular Delivery</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0802645</gtr:grantReference><gtr:abstractText>RNAi is a new form of therapy that allows faulty genes to be switched off in a wide range of genetic diseases and in cancer. The barrier to applying this revolutionary new form of medicine is how to deliver it into the body, since the molecules involved are larger than normal drugs and so cells require some help in taking this material up so it can have its beneficial effect. The main aim of this project is to revolutionise the delivery of these new therapeutics into the skin, as a test organ system by exploiting the penetrating effect of ultrasound activated microbubbles. Skin has the advantage of being on the outside of the body for easy access, and excess human skin from cosmetic surgery (breast reductions and tummy tucks) is readily available for experimentation to optimise delivery of RNAi molecules. In pursuit of this, we will develop an innovative new tool combining chemistry, ultrasound and arrays of microscopic painless needles for fast, effective and reliable delivery into skin at high coverage rates. Once optimised for skin diseases, this hand-held device will be readily adapted for use on internal organs using keyhole surgery methods, so that the potential applications of this device across all branches of medicine are huge. The team assembled in Dundee brings together a leading molecular biologist with a physicist, but supported by further international collaborators with diverse skills across many different fields, in order to piece together elements of technology in ways that have never been done before. The estimated market for solving the therapy delivery problem being tackled here is in the order of 10s of billions of dollars per year.
Ultrasound, as prescribed in the manner presented, looks like a very promising route to achieving that goal.</gtr:abstractText><gtr:technicalSummary>RNA-interference (RNAi) has revolutionised biomedical sciences as a research tool and has enormous potential for treatment a host of genetic diseases and cancer. In 2004, the projected market for this new class of therapeutics was estimated at $25 billion in the USA alone. The major limiting factor preventing RNAi technology from clinical application is effective delivery. The skin is an attractive target organ for delivery development due its accessibility but the stratum corneum, the impermeable barrier layer at the epidermal surface, is difficult to cross. Here we have assembled a multidisciplinary team consisting of a molecular biologist with expertise in genetic skin disease and an physicist highly active in design of microfabrication of new medical devices for ultrasonic delivery of molecules (sonoporation), all based in a new translational research division within the 5* research environment at the University of Dundee. The team is supported by collaborators that include a clinical dermatologist, the CEO of a siRNA biopharma start-up and the leading experts in use of sonoporation for skin delivery and in use of microneedles for trans-stratum corneum delivery. The overarching objective for this project is to revolutionise the delivery of molecular therapeutics across the stratum corneum and into the underlying living tissue. This will be achieved by marrying the latest cutting edge findings drawn from ultrasound driven micro-fluid mechanics, with state-of-the-art RNAi biotechnology. Here, we make a quantum leap in procedures by coupling the initial penetrative passage through the stratum corneum with an active mode of subsequent dispersal into the viable dermis using ultrasound activated microbubbles that contain the siRNA. Delivery testing will involve use of human skin biopsy material. This scientific method, and the hardware developed in support of it are unique, and have not been attempted before.</gtr:technicalSummary><gtr:fund><gtr:end>2010-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>86909</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Molecular Medicine</gtr:department><gtr:description>MRC Milstein Award</gtr:description><gtr:id>AAB1BFD6-30FC-4E33-BBEB-317693E44E9F</gtr:id><gtr:impact>1. Patents under preparation for microfluidics chip now that concept proved. 
This work has been multidisciplinary involving physics and optical engineeing to develop control the microfluidics, fluid mechanics/computational physics to design the chip in the first instance, and in tandem, the inclusion of specialist microbubble formulations (pharmaceutical/biotech/chemical engineering) to ensure longevity of the microbubbles and also their suitability for in vitro use and eventually clinical implementation.
2. Conference paper presented at ICHSIP in Morioka, Japan, highlighting the proof of concept and extended paper under preparation for the journal Optics Express</gtr:impact><gtr:outcomeId>FtLsKssSoZe-1</gtr:outcomeId><gtr:partnerContribution>Consolidation of pilot work and infrastructural development with the injection of a new jointly supervised multidisciplinary team</gtr:partnerContribution><gtr:piContribution>Exploitation of microfluidics expertise to create prototype microbubble generator that will contain our siRNA of choice. 
Utilisation of high speed imaging infrastructure to prove concept of the novel microfluidics chip.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Public Engagement</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>3680AE3A-66F3-4B85-BCA6-464C8694A610</gtr:id><gtr:impact>35 members of the public attended a talk I gave as part of Cafe Scientifique -at the Q &amp;amp; A stage, which lasted over 30 minutes, topics such as ethics in research and the cost of NHS were embraced

I was invited to give the keynote address at the Scottish Science Education Conference 2011, and have also been invited to assist with the development of the Scottish Qualifications Agency's Advanced Higher (A' Level) practical elements.</gtr:impact><gtr:outcomeId>a9XVTThs4mw</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cicass.net</gtr:url><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Group Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>389509FD-C68C-42BA-9C4E-430EFF46D429</gtr:id><gtr:impact>10 members of the public came for a tour of the group and wider division.

Interesting connections with historical figures associated with the University developed.</gtr:impact><gtr:outcomeId>NL8oovM1CqY</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.cicass.net</gtr:url><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>964449</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Basic Technology Translation Award</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/H045368/1</gtr:fundingRef><gtr:id>A7AAA43D-3037-4860-BF69-C375F862F0A8</gtr:id><gtr:outcomeId>XGoieUCMHyk0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>625000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Milstein Award</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0801742</gtr:fundingRef><gtr:id>FC68C302-1D43-4A0E-A7F5-4E1122FAE628</gtr:id><gtr:outcomeId>mZHpygpoqGS0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Access to instrumentation funded by the MRC grant that has divisional impact on a rota basis -
training on the kit.</gtr:description><gtr:id>D6D26954-3A6B-44D1-8356-28355A6243BD</gtr:id><gtr:impact>Developing pilot research with other PIs for future grant funding proposals</gtr:impact><gtr:outcomeId>WnqeNsGeAqX</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Dedicated Cell BioPhysics facility</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>0EABA61E-F7FB-477B-A4B7-7020583457B0</gtr:id><gtr:title>DNA double-strand breaks induced by cavitational mechanical effects of ultrasound in cancer cell lines.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/609f456775640e054ea48a2e8d36b640"><gtr:id>609f456775640e054ea48a2e8d36b640</gtr:id><gtr:otherNames>Furusawa Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>C4gH85VAt7y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6013C3DC-DDCC-4DE7-8DDD-28D802D3E7E5</gtr:id><gtr:title>Enhanced gene transfection using calcium phosphate co-precipitates and low-intensity pulsed ultrasound.</gtr:title><gtr:parentPublicationTitle>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3c75f53f865890b704ad83e9a2dfb7f"><gtr:id>e3c75f53f865890b704ad83e9a2dfb7f</gtr:id><gtr:otherNames>Hassan MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0928-0987</gtr:issn><gtr:outcomeId>EktgLK7voBm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5166634-B45C-4C11-AFAA-E0D1D66D1040</gtr:id><gtr:title>The role of Ca(2+) in ultrasound-elicited bioeffects: progress, perspectives and prospects.</gtr:title><gtr:parentPublicationTitle>Drug discovery today</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3c75f53f865890b704ad83e9a2dfb7f"><gtr:id>e3c75f53f865890b704ad83e9a2dfb7f</gtr:id><gtr:otherNames>Hassan MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1359-6446</gtr:issn><gtr:outcomeId>cvNrUueHbiX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>612F9C80-DB0C-40E4-AF66-17781F95F993</gtr:id><gtr:title>Spatially optimized gene transfection by laser-induced breakdown of optically trapped nanoparticles</gtr:title><gtr:parentPublicationTitle>Applied Physics Letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c72125b333e283c402a97e9c74fcedc"><gtr:id>6c72125b333e283c402a97e9c74fcedc</gtr:id><gtr:otherNames>Arita Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>W1Syie2sUUd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D7C9D8C-BABD-4AC5-8671-1ACD344B4897</gtr:id><gtr:title>On the accuracy of framing-rate measurements in ultra-high speed rotating mirror cameras.</gtr:title><gtr:parentPublicationTitle>Optics express</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/77df3b7b0fc1b1ec7fe4052005647645"><gtr:id>77df3b7b0fc1b1ec7fe4052005647645</gtr:id><gtr:otherNames>Conneely M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1094-4087</gtr:issn><gtr:outcomeId>FNu5oGUngPH</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802645</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>